breast-cancer

Documents about breast-cancer

• Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer#261418ClinicalTrials.gov
• Achieving High Accuracy in Breast Cancer Diagnosis with CNN#301419Mars: Jurnal Teknik Mesin, Industri, Elektro Dan Ilmu Komputer
• Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer#356637ClinicalTrials.gov
• Assessment of risk factors of breast cancer among women in Dodoma, Tanzania: a community-based cross-sectional study#5142Europe PMC
• Deep learning empowered breast cancer diagnosis: Advancements in detection and classification#199278OpenAlex
• Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015–2021)#284222HAL (France)
• Cancer statistics, 2012#6915OpenAlex
• Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics#258679PLOS
• Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK#300243ClinicalTrials.gov
• Adaptive Symptom Self-Management Immunotherapy Study#18578ClinicalTrials.gov
• Digital breast tomosynthesis in breast cancer screening: an ethical perspective#77917PhilArchive
• Understanding breast cancer causes: insights from Jordanian women's awareness#5138Europe PMC
• Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy#181759ClinicalTrials.gov
• A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer#208458ClinicalTrials.gov
• Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)#234421ClinicalTrials.gov
• Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca#343697ClinicalTrials.gov
• Effectiveness of self-management interventions in reducing cancer treatment-related cardiotoxicity in breast cancer survivors: A systematic review#4477Europe PMC
• HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer#346976ClinicalTrials.gov
• Global Cancer Statistics, 2002#6833OpenAlex
• Integrating circulating microRNAs with epidemiological factors enhances breast cancer detection across subtypes: the MCC-Spain study#226465Dipòsit Digital de la Universitat de Barcelona
• PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer#140987ClinicalTrials.gov
• Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)#152429ClinicalTrials.gov
• BMI's Early Echo: Deciphering Adolescent Body Mass Indicator On Adulthood Breast Cancer#167506EliScholar
• Elucidating the physiological and molecular mechanisms of endocrine-disrupting compounds in breast cancer malignancy#212147RUcore, Rutgers University Community Repository
• Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016#215677Ora Oxford University Research
• Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial#250324HAL (France)
• Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.#290971ClinicalTrials.gov
• Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]#369821ClinicalTrials.gov
• Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).#373604ClinicalTrials.gov
• Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial#253006ClinicalTrials.gov
• Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.#162456ClinicalTrials.gov
• An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin#279595ClinicalTrials.gov
• Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study#152612ClinicalTrials.gov
• A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment#310994ClinicalTrials.gov
• Social disparities in the frequency and severity of triple-negative breast cancer at diagnosis in a university hospital in Paris, France: confronting race and ethnic blindness#229837HAL (France)
• The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer#4762Europe PMC
• Comparative survival of breast cancer before and after molecular subtypes#211919Repositorio UNAB
• Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2#249670ClinicalTrials.gov
• Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases#268014ClinicalTrials.gov
• Photothermal and photodynamic therapy using nanomaterials for breast cancer#295614Recep Tayyip Erdoğan University Institutional Repository
• Rural-Urban Disparities and Trends in Cancer Screening: An Analysis of Behavioral Risk Factor Surveillance System Data (2018-2022)#260656Scholar Commons
• Development of predictive models for the prognosis of triple-negative breast cancer using multiple transcriptomic analyses#152679PLOS
• Lavandula stoechas ethanol extracts induce apoptosis in breast, bladder, and glioblastoma cancer cells#351957Recep Tayyip Erdoğan University Institutional Repository
• ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy#363607ClinicalTrials.gov
• Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer#329485ClinicalTrials.gov
• Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70#174866ClinicalTrials.gov
• The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy#303723ClinicalTrials.gov
• Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient#373596ClinicalTrials.gov
• Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors#181763ClinicalTrials.gov
• Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy#195315ClinicalTrials.gov